APA (7th ed.) Citation

alessi, M., Gaudin, C., Grosjean, P., Martin, V., Timsit, S., Mahagne, M., . . . Nighoghossian, N. (2016). Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome. Cerebrovascular Diseases, 42(5/6), 404. https://doi.org/10.1159/000447722

Chicago Style (17th ed.) Citation

alessi, Marie-Christine, et al. "Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome." Cerebrovascular Diseases 42, no. 5/6 (2016): 404. https://doi.org/10.1159/000447722.

MLA (9th ed.) Citation

alessi, Marie-Christine, et al. "Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome." Cerebrovascular Diseases, vol. 42, no. 5/6, 2016, p. 404, https://doi.org/10.1159/000447722.